Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000214952 | SCV000279701 | likely pathogenic | not provided | 2021-12-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 34695666, 28377535, 31526516) |
Labcorp Genetics |
RCV000812933 | SCV000953263 | pathogenic | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2019-03-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed to be de novo in individuals affected with early infantile epileptic encephalopathy (PMID: 28377535, Invitae). ClinVar contains an entry for this variant (Variation ID: 234696). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with histidine at codon 1111 of the GRIN2B protein (p.Arg1111His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. |
Baylor Genetics | RCV001172342 | SCV003836346 | likely pathogenic | Intellectual disability, autosomal dominant 6 | 2022-03-21 | criteria provided, single submitter | clinical testing |